ZNF527 Activators would fall into a category of chemical agents tailored to stimulate the activity of the ZNF527 protein, a member of the zinc finger protein family. Zinc finger proteins are typically characterized by their finger-like protrusions, which involve a zinc ion coordinated with cysteine and histidine residues within the protein structure. These zinc finger domains facilitate binding to DNA, RNA, or other proteins, possibly influencing gene expression, nucleic acid metabolism, or protein-protein interactions. The ZNF527 protein, encoded by the ZNF527 gene, would be presumed to have similar functions, potentially acting as a transcriptional regulator within the nucleus of cells. Activators targeting ZNF527 would be structured to increase the protein's natural ability to bind to its targets or to promote its stability and presence within the nucleus. Such activators might be small organic molecules with the capacity to cross cellular and nuclear membranes, or possibly peptides that mimic natural ligands or interact with regulatory domains of the protein.
To develop ZNF527 Activators, a comprehensive understanding of the ZNF527 protein's structure and function would be paramount. This would involve determining the protein's amino acid sequence, identifying the key structural motifs-especially the zinc finger domains responsible for DNA or protein binding, and understanding the conformation that the protein assumes when it is active. High-resolution structural techniques, such as X-ray crystallography or cryo-electron microscopy, might be employed to visualize ZNF527 at the atomic level, which would be instrumental in identifying potential sites for activator interaction. Parallel to structural studies, biochemical assays would be designed to elucidate the role of ZNF527 in cellular processes, such as its effect on gene expression patterns and its interaction with other proteins or nucleic acids. Such information would guide the synthesis and selection of chemical compounds or biomolecules that could be tested for their ability to modulate the activity of ZNF527. Through a process of screening and chemical optimization, a series of ZNF527 Activators could be developed, each displaying a unique capability to modulate the activity of ZNF527, thereby enhancing its role in the cellular context where it operates.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that may alter chromatin structure, potentially affecting the expression of genes like ZNF527. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that inhibits DNA methyltransferase, possibly leading to the activation of some silenced genes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A metabolite of vitamin A that acts as a signaling molecule, potentially regulating gene expression through retinoic acid receptors. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
An activator of adenylate cyclase, which increases levels of cAMP and may activate signaling pathways leading to changes in gene expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
A diester of phorbol that acts as a protein kinase C activator, potentially influencing transcription factor activity and gene expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
A form of estrogen that can bind to estrogen receptors and potentially regulate gene expression through the estrogen response element (ERE). | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
A synthetic glucocorticoid that can act on glucocorticoid receptors and may influence the expression of certain genes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
A short-chain fatty acid and a histone deacetylase inhibitor, which can lead to a more open chromatin structure and potentially affect gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Used in the treatment of bipolar disorder, which may affect glycogen synthase kinase 3 (GSK-3) activity, and subsequently, gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
A catechin found in green tea, which has been reported to have various biological effects, including potential epigenetic modulation. |